Transcatheter Arterial Chemoembolization Treatment for Vulvar Cancer: A Case Report

Abstract

Vulvar cancer is a rare malignant tumor occurring in elderly postmenopausal women. At present, surgery is the main treatment for vulvar cancer. Chemotherapy alone has no obvious therapeutic effect as a treatment for vulvar cancer, so it is often combined with radiotherapy or surgery. Selective arterial infusion chemotherapy and embolization is rarely used for the treatment of vulvar cancer. A 63-year-old Tibetan woman underwent superselective arteriography and embolization. On the 7th day after the operation, the vulvar tumor was necrotic and fell off, and a skin defect at the left labia majora appeared. This patient had no other serious complications. Arterial embolization can block the blood supply to a vulvar tumor, has an obvious effect in reducing the tumor, and can even induce tumor necrosis and make the tumor fall off. However, the skin defect after necrosis and abscission does not heal easily, and even carries the risk of local bleeding, which should be paid attention to by the interventionalist and oncologist. The clinical effects of transcatheter arterial embolization for vulvar cancer still need to be studied by interventionalists and oncologists.

Utilizing preoperative arterial embolization to minimize blood loss at time of vulvar sarcoma resection: A case report

“…Compared to other pelvic malignancies, data for the use of embolization in the management of vulvar cancers are limited. A case study from 2020 used selective arteriography and embolization in a patient with vulvar SCC and found that this technique led to ischemia and spontaneous separation of the exophytic mass from the surrounding labia, thus decreasing the need for a more morbid intervention ( Zhao and Xue, 2020 ). However, there is a paucity of data to guide the use of this modality in the treatment of vulvar masses, and the literature is even more scarce when it comes to its potential utility in the care of patients with vulvar sarcomas.…”